Heart Diseases
Pathological conditions involving the HEART including its structural and functional abnormalities.
Subtype terms (28)
More specific conditions that are subtypes of Heart Diseases in the MeSH hierarchy.
- Arrhythmias, Cardiac
133 drugs (99 approved, 34 experimental)
- Carcinoid Heart Disease
3 drugs approved
- Cardiac Conduction System Disease
- Cardiac Output, High
3 drugs approved
- Cardiac Output, Low
19 drugs (12 approved, 7 experimental)
- Cardiac Tamponade
- Cardiomegaly
11 drugs (9 approved, 2 experimental)
- Cardiomyopathies
146 drugs (85 approved, 61 experimental)
- Cardiotoxicity
72 drugs (62 approved, 10 experimental)
- Endocarditis
48 drugs (42 approved, 6 experimental)
- Heart Aneurysm
- Heart Arrest
79 drugs (66 approved, 13 experimental)
- Heart Defects, Congenital
108 drugs (81 approved, 27 experimental)
- Heart Failure
535 drugs (265 approved, 270 experimental)
- Heart Neoplasms
- Heart Rupture
- Heart Valve Diseases
84 drugs (66 approved, 18 experimental)
- Myocardial Ischemia
203 drugs (135 approved, 68 experimental)
- Myocardial Stunning
12 drugs (9 approved, 3 experimental)
- Pericardial Effusion
2 drugs approved
- Pericarditis
11 drugs (8 approved, 3 experimental)
- Pneumopericardium
- Post-Cardiac Arrest Syndrome
14 drugs approved
- Postpericardiotomy Syndrome
1 drug approved
- Pulmonary Heart Disease
1 drug approved
- Rheumatic Heart Disease
12 drugs (8 approved, 4 experimental)
- Ventricular Dysfunction
11 drugs (9 approved, 2 experimental)
- Ventricular Outflow Obstruction
5 drugs approved
Drugs by status
Approved for this indication (11)
Phase 4 trials (100)
- morphine
- ivabradine
- fenoldopam
- enalapril
- sterculia gum
- tolvaptan
- fosinopril
- levocarnitine
- dexmedetomidine
- azathioprine
- ramipril
- loperamide
- telmisartan
- alemtuzumab
- zhenyuan
- sevoflurane
- allopurinol
- domperidone
- gallium-68-dotatate
- everolimus
- fludeoxyglucose f-18
- clopidogrel
- esmolol
- ferumoxytol
- captopril
- amlodipine
- warfarin
- aminophylline
- fentanyl
- metformin
- +70 more
Phase 3 trials (116)
- nitroglycerin
- calcium
- encainide
- Acoramidis
- folic acid
- ravulizumab-cwvz
- acetylcysteine
- heparin
- cyclosporine
- telcagepant
- sotalol
- chlorthalidone
- abatacept
- hydrochlorothiazide
- vitamin c
- ambrisentan
- reserpine
- colchicine
- olmesartan
- acetaminophen
- pioglitazone
- anacetrapib
- hepatitis b immune globulin (human)
- imipramine
- methotrexate
- medroxyprogesterone
- nitric oxide
- ibuprofen
- whole blood
- hyaluronidase (bovine)
- +86 more
Phase 2 trials (81)
- ceftriaxone
- fluoxetine
- strepincor
- crd-4730
- acebutolol
- tc99m-tilmanocept
- bone marrow derived mesenchymal stem cells
- orticumab
- nu172
- rilonacept
- degarelix acetate
- cold blood
- pyridoxine
- baricitinib
- ketoglutarate
- 68ga-nodaga-e(c[rgdyk])2
- autologous mononuclear stem cell
- sodium dichloroacetate
- hydralazine
- sodium bicarbonate
- bifidobacterium animalis
- phentermine
- l-epigallocatechin
- alprazolam
- deferoxamine
- pine bark extract
- citrulline
- cannabidiol
- canakinumab
- spermidine
- +51 more
Phase 1 trials (31)
- 64cu-dota-ecl1i
- naltrexone
- ipragliflozin
- carvedilol
- Nitroxyl donor
- chlorhexidine
- isoflurane
- bupropion
- card-024
- nitrate
- human placental derived stem cells
- topiramate
- erythromycin
- mk-8892
- bms-394136
- vitis vinifera
- nan-101
- encenicline
- omega-3 fatty acids
- sildenafil
- allogeneic hematopoietic stem cells
- allogeneic adipose derived mesenchymal stem cell
- zoliflodacin
- pentobarbital
- naloxegol
- wobenzyme
- hm2002
- custirsen
- milademetan
- milrinone
- +1 more
Other trials (86)
- s-methionine
- autologous blood
- bevacizumab
- sodium citrate
- fenofibrate
- nicotine
- acetylcholine chloride
- multivitamins
- indobufen
- dexamethasone
- ubiquinone
- arginine
- apelin
- atropine
- high density lipoprotein
- calcium citrate
- icatibant
- inositol
- cefuroxime
- porcine brain-derived peptide preparation
- thallium-201
- caffeine
- essential oils
- fluconazole
- ranolazine
- nitroprusside
- citalopram
- iopromide
- tramadol
- saffron
- +56 more
Organizations
Organization Involved with Phase 4 Indications (168)
- Washington University in St. Louis
- University of Ottawa
- University of Maryland
- Konkuk University
- University of London
- D'Annunzio University of Chieti–Pescara
- Aarhus University
- University of Texas, San Antonio
- University of California, Los Angeles
- Gyeongsang University
- Hospital Alessandro Manzoni Lecco
- Stanford University
- University of Southern Denmark
- Richmond University
- Universidad Carlos III Madrid
- Guangzhou University
- American Heart Association
- Shenyang Northern Hospital
- Ajou University
- University of Insubria
- Capital Medical University
- Abant Izzet Baysal University
- Chiangmai University
- Huazhong University of Science and Technology
- Jiao Tong University
- University of Heidelberg
- Emory University
- Radboud University
- University of North Carolina at Chapel Hill
- National Taiwan University
- +138 more
Organization Involved with Phase 3 Indications (199)
- Danish Heart Foundation
- National Institute on Aging (NIA)
- McMaster University
- University of Carabobo
- Greater Baltimore Medical Center
- Instituto Dante Pazzanese de Cardiologia
- University of Western Brittany
- Axio Research Corporation
- Queen's University, Belfast
- ZonMw: The Netherlands Organisation for Health Research and Development
- AbbVie
- Leiden University
- George Washington University
- Clinical Evaluation Research Unit at Kingston General Hospital
- Northwestern University
- Dartmouth University
- University of Glasgow
- Cambridge Theranostics Ltd
- Amgen
- Abbott
- King Faisal Specialist Hospital
- SMT KASHIBAI NAVALE MEDICAL COLLEGE
- Kowa
- National Heart Institute, Bach Mai Hospital, Vietnam
- University of Utah
- Kastle Therapeutics, LLC
- The Cleveland Clinic
- Icahn School of Medicine at Mount Sinai
- Hospital Geral Roberto Santos
- Genzyme
- +169 more
Organization Involved with Phase 2 Indications (73)
- Uppsala University
- Orion Corporation
- Richardson Centre for Functional Foods and Nutraceuticals
- ViroMed
- The Physicians' Services Incorporated Foundation
- Microvascular Therapeutics, LLC
- Danone Research
- Guang Anmen Hospital
- XyloCor Therapeutics, Inc.
- Mercy Gilbert Medical Center
- Karp Family Foundation
- Vanderbilt University
- Cadrock Pty. Ltd.
- Cohen Children's Medical Center of New York
- The Campbell Foundation
- University of East Anglia
- Ivy Institute of Stem Cells Co. Ltd
- RTI International
- Translational Research Informatics Center, Kobe, Hyogo, Japan
- Genentech
- University of Cambridge
- Venturis Therapeutics
- Essential Pharmaceuticals, LLC
- University of Birmingham
- Inova Health System
- Oakland University
- Valens Int. d.o.o., Slovenija
- William Beaumont Hospitals
- Government of Poland
- Gift of Life International
- +43 more
Organization Involved with Phase 1 Indications (16)
- Asklepion
- Shahid Beheshti University of Medical Sciences
- Lee's Pharmaceutical
- Taipei Veteran General hospital
- Trust Bio-sonics, Inc.
- Liuhuaqiao Hospital
- StatPlus, Inc.
- Thoratec
- Masih Daneshvari Hospital
- Cardiovascular Research Associates
- Brain & Behavior Research Foundation
- Kuopio University Hospital
- University of Kentucky
- Chiesi
- University of Paris
- University of Eastern Finland
Organization Involved with Other Experimental Indications (54)
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Beijing Municipal Health Bureau
- Tibet Kang Zhe Pharmaceutical Technology Co., Ltd
- Alta Bates Summit Medical Center
- University of Zurich
- United Therapeutics
- University of Maribor
- Loma Linda University
- Yorkshire Cancer Research
- University of Lausanne
- Haemonetics Corporation
- Katholieke Universiteit Leuven
- Dr. Sami Ulus Children's Hospital
- Qingdao Fifth People's Hospital
- St. John's Research Institute
- University of Texas, Austin
- Karolinska Institute
- Free University of Brussels
- The Gerber Foundation
- British Heart Foundation
- University of Edinburgh
- Maastricht University
- University of Geneva
- Prolacta Bioscience
- Tianjin University of Traditional Chinese Medicine
- University of Leeds
- Osaka University
- University of Nottingham
- Shengjing Hospital
- Advocate Healthcare
- +24 more